Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

Unique biomarker in urine may offer non-invasive means of detecting prostate cancer

Unique biomarker in urine may offer non-invasive means of detecting prostate cancer

Targeted therapy slows disease progression and improves survival for prostate cancer

Targeted therapy slows disease progression and improves survival for prostate cancer

Modern chemo more effective than second targeted hormone therapy against resistant prostate cancer

Modern chemo more effective than second targeted hormone therapy against resistant prostate cancer

Breast, ovarian cancer drug more effective than targeted hormone therapy in some men with prostate cancer

Breast, ovarian cancer drug more effective than targeted hormone therapy in some men with prostate cancer

Men with prostate cancer can be spared postoperative radiotherapy

Men with prostate cancer can be spared postoperative radiotherapy

High-dose radiation effective for men whose prostate cancer has spread, trial shows

High-dose radiation effective for men whose prostate cancer has spread, trial shows

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

Long-term hormone therapy does more harm than good for men with low PSAs after prostate surgery

Study shows miRNAs in semen as non-invasive biomarkers for prostate cancer

Study shows miRNAs in semen as non-invasive biomarkers for prostate cancer

Prostate cancer risk linked to assisted reproduction techniques

Prostate cancer risk linked to assisted reproduction techniques

Study explores link between assisted reproduction and prostate cancer risk

Study explores link between assisted reproduction and prostate cancer risk

Reactivating ‘tumor suppressor’ genes could offer new therapeutic approach for cancer

Reactivating ‘tumor suppressor’ genes could offer new therapeutic approach for cancer

Men with prostate cancer want access to female doctors

Men with prostate cancer want access to female doctors

New genetic test could help avoid unnecessary prostate cancer surgery

New genetic test could help avoid unnecessary prostate cancer surgery

Bath researchers identify promising prostate cancer drug candidates

Bath researchers identify promising prostate cancer drug candidates

Survey: Men have low levels of awareness about prostate health and function

Survey: Men have low levels of awareness about prostate health and function

Non-viral gene delivery method more effective and safer than standard viral approaches

Non-viral gene delivery method more effective and safer than standard viral approaches

Discovery provides potential therapeutic target for prostate cancers with PTEN mutation

Discovery provides potential therapeutic target for prostate cancers with PTEN mutation

Transperineal prostate biopsy minimizes risk of infection, may increase detection rate

Transperineal prostate biopsy minimizes risk of infection, may increase detection rate

U-M and Karmanos receive NCI grant to find new solutions for prostate cancer

U-M and Karmanos receive NCI grant to find new solutions for prostate cancer